We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
Cap. Flow
+$1.58B
Cap. Flow %
11.22%
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$110M
2
AAPL icon
Apple
AAPL
+$89M
3
MSFT icon
Microsoft
MSFT
+$81.1M
4
AMZN icon
Amazon
AMZN
+$54.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$45.4M

Top Sells

Rank Stock Value
1
PFG icon
Principal Financial Group
PFG
+$4.8M
2
KEY icon
KeyCorp
KEY
+$4.08M
3
SOLS
Solstice Advanced Materials
SOLS
+$3.06M
4
VLO icon
Valero Energy
VLO
+$2.61M
5
MNST icon
Monster Beverage
MNST
+$2.4M

Sector Composition

Rank Sector Weight
1 Technology 35.95%
2 Financials 11.04%
3 Consumer Discretionary 10.63%
4 Communication Services 10.59%
5 Healthcare 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRX
1426
Marex Group Limited Ordinary Shares
MRX
$5.13B
$222K ﹤0.01%
+4,990
New +$197K
BHE icon
1427
Benchmark Electronics
BHE
$2.65B
$222K ﹤0.01%
+3,954
New +$213K
DYN icon
1428
Dyne Therapeutics
DYN
$4.87B
$221K ﹤0.01%
+12,208
New +$211K
MCY icon
1429
Mercury Insurance
MCY
$5.69B
$221K ﹤0.01%
+2,505
New +$224K
SNY icon
1430
Sanofi
SNY
$107B
$219K ﹤0.01%
+4,550
New +$212K
ANDE icon
1431
Andersons Inc
ANDE
$2.17B
$219K ﹤0.01%
+3,045
New +$196K
AMRX icon
1432
Amneal Pharmaceuticals
AMRX
$6.27B
$218K ﹤0.01%
17,556
+5,706
+48% +$76.6K
KEP icon
1433
Korea Electric Power
KEP
$15.3B
$218K ﹤0.01%
+15,285
New +$289K
BANF icon
1434
BancFirst
BANF
$3.71B
$217K ﹤0.01%
+1,997
New +$222K
FBNC icon
1435
First Bancorp
FBNC
$2.63B
$217K ﹤0.01%
+3,845
New +$219K
BEAM icon
1436
Beam Therapeutics
BEAM
$3.15B
$216K ﹤0.01%
9,069
+1,495
+20% +$41.5K
VRRM icon
1437
Verra Mobility
VRRM
$670M
$216K ﹤0.01%
15,112
+2,489
+20% +$45.6K
OSW icon
1438
OneSpaWorld
OSW
$2.66B
$215K ﹤0.01%
+9,388
New +$200K
FBK icon
1439
FB Financial Corp
FBK
$2.88B
$215K ﹤0.01%
+4,147
New +$233K
APAM icon
1440
Artisan Partners
APAM
$3.09B
$215K ﹤0.01%
5,916
+949
+19% +$38.8K
NMRK icon
1441
Newmark Group
NMRK
$2.82B
$215K ﹤0.01%
14,310
+2,711
+23% +$42.8K
DNOW icon
1442
DNOW Inc
DNOW
$2.94B
$214K ﹤0.01%
18,000
+2,927
+19% +$39.6K
TNGX icon
1443
Tango Therapeutics
TNGX
$4.26B
$214K ﹤0.01%
+10,238
New +$143K
IBRX icon
1444
ImmunityBio
IBRX
$8.9B
$214K ﹤0.01%
27,849
+4,681
+20% +$32K
ZD icon
1445
Ziff Davis
ZD
$1.91B
$213K ﹤0.01%
5,076
-2,689
-35% -$98.9K
MTX icon
1446
Minerals Technologies
MTX
$2.25B
$212K ﹤0.01%
+2,993
New +$206K
NVO
1447
Novo Nordisk
NVO
$205B
$212K ﹤0.01%
5,772
+1,424
+33% +$67.5K
TBBK icon
1448
The Bancorp
TBBK
$2.71B
$212K ﹤0.01%
3,937
+613
+18% +$36.7K
SAM icon
1449
Boston Beer
SAM
$1.88B
$212K ﹤0.01%
+918
New +$206K
NBTB icon
1450
NBT Bancorp
NBTB
$2.67B
$210K ﹤0.01%
+4,934
New +$214K
56 57
58
59 60

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Xponance's Q1 2026 Portfolio in Review

As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.

  • Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
  • Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
  • Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
  • Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
  • Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
  • Xponance opened 165 new positions and closed 49 in Q1 2026.
  • Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.